The EVERY Co and Onego Bio Merger Talks
The EVERY Co has urged a court in Wisconsin to dismiss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents.
Alt-egg startups The EVERY Company and Onego Bio had been discussing a merger before talks fell apart and Onego sued its rival, according to court documents.
- The valuation figure was disclosed in a court filing.
- The company has since asked the court to seal that information.
Details of the talks were shared in an October 28 legal filing by The EVERY Co, which sought to toss a lawsuit from Onego Bio.
The IP at issue covers the production of ovalbumin, the primary protein in egg white, via precision fermentation.
The EVERY Co uses yeast (Komagataella phaffii) as its host microorganism, while Onego Bio uses fungus (Trichoderma reesei).
Author's summary: Merger talks between The EVERY Co and Onego Bio failed.